Laurent Fraisse
Direktor/Vorstandsmitglied bei GENOWAY
Aktive Positionen von Laurent Fraisse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GENOWAY | Direktor/Vorstandsmitglied | - | - |
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2018 | - |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Laurent Fraisse
Ehemalige bekannte Positionen von Laurent Fraisse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SANOFI | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Corporate Officer/Principal | - | - |
Ausbildung von Laurent Fraisse
Institut National Polytechnique de Toulouse | Doctorate Degree |
Statistik
International
Frankreich | 6 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Doctorate Degree | 1 |
Sektoral
Commercial Services | 3 |
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GENOWAY | Health Technology |
SANOFI | Commercial Services |
Private Unternehmen | 2 |
---|---|
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Commercial Services |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Nosopharm SAS operates as a biotechnology company. It develops an anti-infective drug platform that is based on the medicinal chemistry of a novel antibiotic class used to cure life-threatening multi-resistant hospital-acquired infections. The company was founded by Philippe Villain-Guillot and Maxime Gualtieri in February 2009 and is headquartered in Nimes, France. | Health Technology |
- Börse
- Insiders
- Laurent Fraisse
- Erfahrung